Targeting tumor‐associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Tumor-associated fibroblasts are key regulators of tumorigenesis. In contrast to tumor cells, which are genetically unstable and mutate frequently, the presence of genetically more stable fibroblasts in the tumor-stromal compartment makes them an optimal target for cancer immunotherapy. These cells are also the primary source of collagen type I, which contributes to decreased chemotherapeutic drug uptake in tumors and plays a significant role in regulating tumor sensitivity to a variety of chemotherapies. To specifically kill tumor-associated fibroblasts, we constructed an oral DNA vaccine targeting fibroblast activation protein (FAP), which is specifically overexpressed by fibroblasts in the tumor stroma. Through CD8+ T cell-mediated killing of tumor-associated fibroblasts, our vaccine successfully suppressed primary tumor cell growth and metastasis of multidrug-resistant murine colon and breast carcinoma. Furthermore, tumor tissue of FAP-vaccinated mice revealed markedly decreased collagen type I expression and up to 70% greater uptake of chemotherapeutic drugs. Most importantly, pFap-vaccinated mice treated with chemotherapy showed a 3-fold prolongation in lifespan and marked suppression of tumor growth, with 50% of the animals completely rejecting a tumor cell challenge. This strategy opens a new venue for the combination of immuno- and chemotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, depleting fibroblast activation protein (FAP)+ CAFs via a FAP vaccine decreases collagen density and improves chemoresistance in mouse models [99].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Stromal Effects on Mammary Gland Development and Breast Cancer
Wiseman, B. S., & Werb, Z. (2002) · Science · doi:10.1126/science.1067431 · Cited by 923
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection
Baxter, L. T., & Jain, R. K. (1989) · Microvascular Research · doi:10.1016/0026-2862(89)90074-5 · Cited by 894
Cited by
Items 601–648 of 648
O’Fee, K., Burley, A., & Wilkins, A. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90005-5
Madhusoodanan, L., Viglianti, B. L., & Scott, P. J. H. (2025) · Seminars in Roentgenology · doi:10.1053/j.ro.2025.04.001
FAP α+ CAFs: Targeting the Tumor Microenvironment for Revolutionary Cancer Therapies
Ahmad, S., Zahoor, M., Esa, M., & Ullah, R. (2025) · Current Cancer Therapy Reviews · doi:10.2174/0115733947388031250715112019
Fibroblast Activation Protein (FAP): A Key Modulator of the Cancer Microenvironment
Mousavi, M. J., Karami, J., Alimohammadi, M., Solaymani‐Mohammadi, F., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_357
Vaccines in RCC: Clinical and Biological Relevance
Lowe, D. B., Finke, J. H., García, J. A., & Storkus, W. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_22
Liu, Y., Sun, Y., Wang, P., Li, S., Yiwei, D., Zhou, M., 石必枝, Jiang, H., Sun, R., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26581793
Martínez Blanco, Á. (2025) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Wang, L., Ji, D., Luo, N., Sun, T., Liu, X., Ma, Y., Jiang, Y., Wang, X., Liu, G., & Ling, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172263
Haque, I., Kambhampati, S., & Banerjee, S. K. (2026) · Cancers · doi:10.3390/cancers18050826
“Preclinical investigations demonstrate that an adenoviral vector encoding FAP induces robust CD8 + T-cell activation, resulting in significant suppression of both primary and metastatic disease in multidrug-resistant mouse models [43].”
Ali, F. M., MOSTAFA, A., ODABI, N., GADRI, R. M., ALLAM, M. S. E., & ALSALEH, M. A. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i3.57660 · Cited by 1
Role of stroma and Wound Healing in carcinoma response to ionizing radiation
Arshad, A. (2014) · theses.fr (ABES) · doi:10.70675/64b07d78z5f57z479ezb5e7za4825a30617d
Etude de la reprogrammation métabolique de l' adénocarcinome canalaire pancréatique
Olivares, O. (2015) · theses.fr (ABES) · doi:10.70675/ef2c6a2czab6dz4a68z8004z1ade8605dadc
Benyahia, Z. (2016) · theses.fr (ABES) · doi:10.70675/52b76651za30az4adfz9312zbc88a5bd6892
Ziani, L. (2017) · theses.fr (ABES) · doi:10.70675/a0f25460zb6f0z4657z9194zefca731af42c · Cited by 1
Rôles de l’autophagie dans l'homéostasie des cellules souches intestinales
Trentesaux, C. (2018) · theses.fr (ABES) · doi:10.70675/6bad110bz19b1z4cd6z81d0z74d0fb1e27f3
Saccone, M. A. (2019) · theses.fr (ABES) · doi:10.70675/d8995276z6866z4372zbbc2z271914e8a438
Stromal cells in mammary gland development and cancer
Benabid, A. (2020) · theses.fr (ABES) · doi:10.70675/8612698bz63e1z401eza0caz2b4d989c570f
Lecacheur, M. (2021) · theses.fr (ABES) · doi:10.70675/9c0b4d17zd8d8z498ezb534z3096acf22d56
da Silva, A. C. R., Baltazar, F., & Afonso, J. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_5
Zhang, L., Zhang, K. C., Chen, Z. F., & Xh, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1907838 · Cited by 1
Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion
Maqbool, M., Surendranath, A., Baba, S. K., Jawwad, T., Elfaki, I., Mir, R., Kumar, R., Shahab Uddin, M. S., Haris, M., Macha, M. A., et al. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0045
Paraiso, P., Li, L., Ma, H., Illi, N., Piet, A., Handula, M., de Ridder, C., Stuurman, D. C., van Deurzen, C. H. M., & Seimbille, Y. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107643
Dana, P., Taweechaipaisankul, A., Phoraksa, O., Rattanatayarom, M., Chonniyom, W., Punnakitikashem, P., Tanyapanyachon, P., & Saengkrit, N. (2026) · ACS Omega · doi:10.1021/acsomega.6c03367
dos Reys, M. P., Rodrigues, M. Â., Nakagaki, K. Y. R., de Oliveira, A. L. C. B., & Cassali, G. D. (2026) · The Veterinary Journal · doi:10.1016/j.tvjl.2026.106891
Liu, D., Yu, D., Chen, M., Dai, T., Li, X., Su, D., 郑菊艳, & Zhang, Y. (2026) · iScience · doi:10.1016/j.isci.2026.117696
“49 Subsequent research demonstrated that fibroblasts in the TME are heterogeneous, and using α SMA or desmin alone as markers cannot identify all CAFs.”
Zhang, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1927031
“FAP-directed cells or vaccines reduced stroma and improved therapy in several mouse models, but FAP is also expressed by normal stromal populations and FAP-targeted T cells caused cachexia and bone-marrow toxicity in mice (Tran et al., 2013; Loeffler et al., 2006).”
Visintin, A. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Gan, L., Liu, Z., Cao, L., Meng, X., Liu, X., Wang, X., & He, Y. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00837-6
“Similarly, the LOXL2-specific antibody AB0023 reduced activated fibroblasts, desmoplasia, and tumor-associated vascular remodeling, while inhibiting primary and metastatic tumor growth in xenograft models [164].”
毕妍娜, Zhao, Y., Ge, Y., 陳, 哲., Zhao, L., & Sun, G. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218859
Banihashemian, S. S., Akbari, M. E., Pirayesh, E., Divband, G., Shahrnoy, A. A., Nami, R., & Nasiri, M. (2026) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006693
Carcinoma-Associated Fibroblasts in Lung Cancer
Navab, R., Bandarchi, B., & Tsao, M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0772-1_10
Metadata
- Authors
- Loeffler, M.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Loeffler, M.
- ORCID
- Loeffler, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1955-1962
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1481657
- OpenAlex
- W2002689409
- Cited by
- 633
- References
- 51
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 41 · 2023: 58 · 2022: 33 · 2021: 56 · 2020: 43 · 2019: 39 · 2018: 28 · 2017: 32 · 2016: 39 · 2015: 46 · 2014: 33 · 2013: 33 · 2012: 28
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- National Cancer Institute (CA 83856, R01CA083856)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer-associated fibroblasts, fibroblast activation protein, oral DNA vaccine, type I collagen, tumor stroma, chemosensitization, multidrug resistance, colon cancer, breast cancer, metastasis, chemoimmunotherapy
- MeSH terms
- Fibroblast Activation Protein Alpha, Animals, Female, Fibroblasts, Membrane Proteins, Mice, Inbred BALB C, Neoplasms, Endopeptidases, Recombinant Fusion Proteins, Serine Endopeptidases, Survival Rate, Gelatinases, CD8-Positive T-Lymphocytes, Vaccines, DNA, Cancer Vaccines, Collagen Type I, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.